DE69012784D1 - Transformiertes Shigella. - Google Patents

Transformiertes Shigella.

Info

Publication number
DE69012784D1
DE69012784D1 DE69012784T DE69012784T DE69012784D1 DE 69012784 D1 DE69012784 D1 DE 69012784D1 DE 69012784 T DE69012784 T DE 69012784T DE 69012784 T DE69012784 T DE 69012784T DE 69012784 D1 DE69012784 D1 DE 69012784D1
Authority
DE
Germany
Prior art keywords
strain
wild strain
shigella
invasive
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69012784T
Other languages
English (en)
Inventor
Philippe Sansonetti
Maria Lina Bernardi Bernardini
Annick Fontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE69012784D1 publication Critical patent/DE69012784D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69012784T 1990-02-06 1990-02-06 Transformiertes Shigella. Expired - Lifetime DE69012784D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400326A EP0441071B1 (de) 1990-02-06 1990-02-06 Transformiertes Shigella

Publications (1)

Publication Number Publication Date
DE69012784D1 true DE69012784D1 (de) 1994-10-27

Family

ID=8205683

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69012784T Expired - Lifetime DE69012784D1 (de) 1990-02-06 1990-02-06 Transformiertes Shigella.

Country Status (6)

Country Link
EP (1) EP0441071B1 (de)
JP (1) JPH04505399A (de)
AT (1) ATE111957T1 (de)
CA (1) CA2051434A1 (de)
DE (1) DE69012784D1 (de)
WO (1) WO1991012321A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US6150170A (en) * 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5877159A (en) * 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
WO1997014810A1 (en) * 1995-10-18 1997-04-24 Pharmacia & Upjohn Company Use of procaryotic hosts for expression of gene in eucaryotic cells
GB9806449D0 (en) 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
BRPI0816842A2 (pt) * 2007-04-25 2019-09-24 The Us Secretary Of The Army Walter Reed Army Insitute Of Research cepa de vacina de shigella, composição imunogênica, vacina, kit para o tratamento de um indivíduo e método.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR242989A1 (es) * 1988-07-15 1993-06-30 Inst Pasteur I Nat De La Sante Metodo para modificar una cepa salvaje de una shigella entero-invasora para producir una cepa modificada apta para preparar una vacuna contra la cepa salvaje y cepa de shigella asi modificada.

Also Published As

Publication number Publication date
WO1991012321A1 (en) 1991-08-22
JPH04505399A (ja) 1992-09-24
CA2051434A1 (en) 1991-08-07
ATE111957T1 (de) 1994-10-15
EP0441071B1 (de) 1994-09-21
EP0441071A1 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
ES2054708T3 (es) Gen de resistencia frente a fosfinotricina, activo en plantas y su utilizacion.
KR900700603A (ko) 리보자임
ATE127694T1 (de) Lebende impfstoffe.
DE68929343T2 (de) Modifizierte Zellen mit Resistenz gegen Retroviralinfektionen
ATE169061T1 (de) Methode des gentransfers mittels retrotransposons
RS49981B (sr) Upotreba derivata hidroksilamina za dobijanje farmaceutskih kompozicija korisnih za povećanje ekspresije i aktivnosti molekulskih šaperona
Hwang et al. Kinetic and mutational dissection of the two ATPase activities of terminase, the DNA packaging enzyme of bacteriophage λ
ATE138384T1 (de) Olionukleotidalkylphosphonate und - phosphonothioate
DK0724642T3 (da) Nukleinsyrevektor, sammensætning indeholdende en sådan vektor og vaccine til immunisering mod hepatitis
GR880100421A (el) Γονιδιο που αποικοδομει αλοαρυλνιτριλιο,η χρηση του και κυτταρα που περιεχουν το γονιδιο.
DE69806408T2 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
ATE111957T1 (de) Transformiertes shigella.
DE69232231T2 (de) Manipulierung der Anzahl von Gen-Kopien bei Bordetella
ES2074280T3 (es) Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria.
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
NO892029L (no) Fremgangsmaate ved spesifikk genetisk manipulering av mikroorganisme.
Kohmoto et al. The mitochondrion: the prime site for a host-selective toxin (ACR-toxin I) produced by Alternaria alternata pathogenic to rough lemon
NO951277L (no) Desulfatohirudin med höy molekylvekt
KR900702025A (ko) 형질 변환된 시겔라(Shigella)
ATE66690T1 (de) Unikale, monogenetische streptokinase, ihre herstellung und verwendung.
SE8205247L (sv) Fiskvacciner
Dhillon et al. Local anaesthetic and vasoconstrictor agents used in ENT
Dhillon et al. Photodynamic therapy
MX9708615A (es) Terapia de genes animales.
FI893346A0 (fi) Icke-reverterande rna-virus.

Legal Events

Date Code Title Description
8332 No legal effect for de